These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11393329)

  • 21. Potential role of fluoroquinolones in the treatment of bacterial meningitis.
    Modai J
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):291-5. PubMed ID: 1864289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003).
    Fedler KA; Jones RN; Sader HS; Fritsche TR
    Diagn Microbiol Infect Dis; 2006 Jun; 55(2):157-64. PubMed ID: 16529904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.
    Onrust SV; Lamb HM; Balfour JA
    Drugs; 1998 Nov; 56(5):895-928. PubMed ID: 9829160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.
    Carson C; Naber KG
    Drugs; 2004; 64(12):1359-73. PubMed ID: 15200349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.
    Balfour JA; Lamb HM
    Drugs; 2000 Jan; 59(1):115-39. PubMed ID: 10718103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the fluoroquinolones.
    Guay DR
    Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolones in children: update of the literature.
    Bacci C; Galli L; de Martino M; Chiappini E
    J Chemother; 2015 Oct; 27(5):257-65. PubMed ID: 26099190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose intravenous fluoroquinolones in the treatment of severe infections.
    Modai J
    J Chemother; 1999 Dec; 11(6):478-85. PubMed ID: 10678789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symposium on antimicrobial therapy. VII. The fluoroquinolones.
    Greenfield RA
    J Okla State Med Assoc; 1993 Apr; 86(4):166-74. PubMed ID: 8387106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.
    Jones RN; Pfaller MA
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S16-23. PubMed ID: 10984323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic focus. The fluoroquinolones.
    James DG
    Br J Clin Pract; 1989 Feb; 43(2):66-7. PubMed ID: 2679837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoroquinolones.
    Hendershot EF
    Infect Dis Clin North Am; 1995 Sep; 9(3):715-30. PubMed ID: 7490440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of oral fluoroquinolones in nursing home patients.
    File TM; Tan JS
    Drugs Aging; 1992; 2(4):310-29. PubMed ID: 1504445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fluoroquinolones in respiratory infections].
    Mouton Y; Leroy O
    Presse Med; 1994 Nov; 23(35):1616-20. PubMed ID: 7831243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group].
    Yamaguchi K; Miyazaki S; Kashitani F; Iwata M; Kanda M; Tsujio Y; Okada J; Tazawa Y; Watanabe N; Uehara N; Igari J; Oguri T; Kaimori M; Kawamura C; Iinuma Y; Nisawataira T; Tashiro H; Ueno K; Ishigo S; Yasujima M; Kawahara S; Itoh C; Yoshida T; Yamanaka K; Toyoshima S; Katoh J; Kudoh M; Matsushima T; Niki Y; Miyashita N; Funato T; Kaku M; Sato N; Saito Y; Ishii K; Kuwabara M; Hongo T; Negayama K; Kamihira S; Miyazaki Y; Takii M; Ishii M; Nakagawa K; Ono J; Takada T; Murakami N; Taira M; Tamaki I; Matsudou Y; Nakasone I
    Jpn J Antibiot; 2000 Jun; 53(6):387-408. PubMed ID: 10955236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
    Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD; D'Azevedo PA; Francisco W
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.